$SOAN After further discussions with our senior advisors we have decided to file with the FDA utilizing 505b (Orphan Drug Status). At this time we are interviewing CRO's while outlining the entire time process for recruitment of patients for clinical trials. #MultipleSclerosis
$SOAN After further discussions with our senior advisors we have decided to file with the FDA utilizing 505b (Orphan Drug Status). At this time we are interviewing CRO's while outlining the entire time process for recruitment of patients for clinical trials. #MultipleSclerosis
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.